Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia
Autor: | Maja Oroz, Robert Beluzić, Oliver Vugrek, Josip Begovac, Tomaž Mark Zorec, Snježana Židovec Lepej, Maja M. Lunar, Ana Planinić, Filip Rokić, Petra Korać, Mario Poljak |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Croatia / epidemiology Male Epidemiology Human immunodeficiency virus (HIV) lcsh:Medicine HIV Infections Drug resistance medicine.disease_cause law.invention HIV Infections / epidemiology law Genotype Prevalence Medicine lcsh:Science Hiv resistance Phylogeny Molecular Epidemiology Multidisciplinary HIV Infections / virology biology Molecular medicine HIV-1 / isolation & purification 3. Good health Integrase Transmission (mechanics) Female Anti-HIV Agents / pharmacology Anti-HIV Agents / therapeutic use Adult Drug Resistance Viral / genetics Anti-HIV Agents Croatia 030106 microbiology HIV molekularna epidemiologija transmisijski klasteri filogenetska analiza filodinamska analiza sekvenciranje nove generacije Article 03 medical and health sciences HIV Infections / transmission Drug Resistance Viral Humans Clinical care Molecular epidemiology business.industry lcsh:R Virology Molecular Typing 030104 developmental biology HIV-1 / drug effects Mutation biology.protein HIV-1 lcsh:Q HIV-1 / genetics business |
Zdroj: | Scientific Reports Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019) |
DOI: | 10.1038/s41598-019-53520-8 |
Popis: | Molecular epidemiology of HIV-1 infection in treatment-naive HIV-1 infected persons from Croatia was investigated. We included 403 persons, representing 92.4% of all HIV-positive individuals entering clinical care in Croatia in 2014–2017. Overall prevalence of transmitted drug resistance (TDR) was estimated at 16.4%. Resistance to nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside RTI (NNRTIs) and protease inhibitors (PIs) was found in 11.4%, 6.7% and 2.5% of persons, respectively. Triple-class resistance was determined in 2.2% of individuals. In addition, a single case (1.0%) of resistance to integrase strand-transfer inhibitors (InSTIs) was found. Deep sequencing was performed on 48 randomly selected samples and detected additional TDR mutations in 6 cases. Phylogenetic inference showed that 347/403 sequences (86.1%) were part of transmission clusters and identified forward transmission of resistance in Croatia, even that of triple-class resistance. The largest TDR cluster of 53 persons with T215S was estimated to originate in the year 1992. Our data show a continuing need for pre-treatment HIV resistance testing in Croatia. Even though a low prevalence of resistance to InSTI was observed, surveillance of TDR to InSTI should be continued. |
Databáze: | OpenAIRE |
Externí odkaz: |